0001176256-20-000250.txt : 20200630 0001176256-20-000250.hdr.sgml : 20200630 20200630114353 ACCESSION NUMBER: 0001176256-20-000250 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20200629 FILED AS OF DATE: 20200630 DATE AS OF CHANGE: 20200630 FILER: COMPANY DATA: COMPANY CONFORMED NAME: IMV Inc. CENTRAL INDEX KEY: 0001734768 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: Z4 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38480 FILM NUMBER: 201001233 BUSINESS ADDRESS: STREET 1: 130 EILEEN STUBBS AVE. STREET 2: SUITE 19 CITY: DARTMOUTH STATE: A5 ZIP: B3B 2C4 BUSINESS PHONE: 9024921819 MAIL ADDRESS: STREET 1: 130 EILEEN STUBBS AVE. STREET 2: SUITE 19 CITY: DARTMOUTH STATE: A5 ZIP: B3B 2C4 FORMER COMPANY: FORMER CONFORMED NAME: Immunovaccine Inc. DATE OF NAME CHANGE: 20180316 6-K 1 imv6knr200630.htm REPORT OF FOREIGN PRIVATE ISSUER FOR THE MONTH OF JUNE, 2020 Filed by e3 Filing, Computershare 1-800-973-3274 - IMV Inc. - Form 6-K


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of June, 2020

Commission File Number: 001-38480

IMV Inc.
(Name of registrant)

130 Eileen Stubbs Avenue, Suite 19 Dartmouth, Nova Scotia B3B 2C4, Canada

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

[   ] Form 20-F [ X ] Form 40-F

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): [   ]

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): [   ]





SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

  IMV Inc.
 
Date: June 29, 2020 By: /s/ Pierre Labbé
  Name: Pierre Labbé
  Title: Chief Financial Officer

 







EX-99.1 2 exhibit99-1.htm NEWS RELEASE DATED JUNE 29, 2020 Exhibit 99.1
Exhibit 99.1

Media Release


IMV announces Annual and Special Meeting of Shareholders voting results

Dartmouth, Nova Scotia; June 29, 2020 – IMV Inc. (“IMV” or the “Company”) (Nasdaq: IMV; TSX: IMV), a clinical-stage biopharmaceutical company, today announced the voting results from its annual and special meeting of shareholders held on June 29, 2020 (the “Meeting”).

Based on the votes received, all resolutions were accepted including the election of directors, for whom details of the votes are as follows:

Name of
nominee
Votes cast FOR % of votes
cast FOR
Votes
Withheld
% of
votes
Withheld
Andrew Sheldon 24,031,180 96.65% 831,947 3.35%
James W. Hall 22,671,885 91.19% 2,191,242 8.81%
Julia P. Gregory 24,738,803 99.50% 124,324 0.50%
Frederic Ors 24,300,178 97.74% 562,950 2.26%
Wayne Pisano 24,454,084 98.35% 409,043 1.65%
Shermaine Tilley 24,738,126 99.50% 125,001 0.50%
Markus Warmuth 24,726,048 99.45% 137,079 0.55%

Shareholders approved the appointment of PricewaterhouseCoopers, LLP, Chartered Professional Accountants, as independent auditor for the Company for the ensuing year and that the board of directors of the Company be authorized to fix its remuneration.

In addition, all amendments to the deferred share unit plan of the Company as described in the management information circular dated May 25, 2020 (the “Circular”) were approved by the shareholders.





Please refer to the Circular available on SEDAR at www.sedar.com for more information on the business transacted at the Meeting. A report on voting results will also be filed on SEDAR.

Departure of Joseph Sullivan Senior Vice President, Business Development

Joseph Sullivan, Senior Vice President, Business Development is leaving IMV to pursue another opportunity. Frederic Ors, Chief Executive Officer commented: ”I want to take this opportunity to thank Joe for his contribution to IMV and wish him the best in his next challenge.”

About IMV

IMV Inc. is a clinical stage biopharmaceutical company dedicated to making immunotherapy more effective, more broadly applicable, and more widely available to people facing cancer and other serious diseases. IMV is pioneering a new class of cancer-targeted immunotherapies and vaccines based on the Company’s proprietary drug delivery platform. This patented technology leverages a novel mechanism of action that enables the programming of immune cells in vivo, which are aimed at generating powerful new synthetic therapeutic capabilities. IMV’s lead candidate, DPX-Survivac, is a T cell-activating immunotherapy that combines the utility of the platform with a target: survivin. IMV is currently assessing DPX-Survivac as a monotherapy in advanced ovarian cancer, as well as a combination therapy in multiple clinical studies with Merck. IMV is also developing a DPX-based vaccine to fight against COVID-19.

###

Source: IMV Inc.

Investor Relations

Marc Jasmin, Senior Director, Investor Relations, IMV
O: (902) 492-1819 ext : 1042
M: (514) 617-9481 E: mjasmin@imv-inc.com

Josh Rappaport, Director, Stern IR
O: (212) 362-1200
E: josh.rappaport@sternir.com

Media

Delphine Davan, Director of Communications, IMV
M: (514) 968-1046 E: ddavan@imv-inc.com



GRAPHIC 3 exhibit99-1x1x1.jpg begin 644 exhibit99-1x1x1.jpg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end